195 related articles for article (PubMed ID: 6794445)
1. Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1981 May; 19(5):789-93. PubMed ID: 6794445
[TBL] [Abstract][Full Text] [Related]
2. Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Dec; 22(6):1082-3. PubMed ID: 6818900
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
Aznar J; García Iglesias MC; Perea EJ
J Antimicrob Chemother; 1984 Feb; 13(2):129-32. PubMed ID: 6423613
[TBL] [Abstract][Full Text] [Related]
4. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
Auckenthaler R; Wilson WR; Wright AJ; Washington JA; Durack DT; Geraci JE
Antimicrob Agents Chemother; 1982 Sep; 22(3):448-52. PubMed ID: 6958215
[TBL] [Abstract][Full Text] [Related]
5. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
Indrelie JA; Wilson WR; Matsumoto JY; Geraci JE; Washington JA
Antimicrob Agents Chemother; 1984 Dec; 26(6):909-12. PubMed ID: 6596907
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.
Gombert ME; Berkowitz LB; Cummings MC
Antimicrob Agents Chemother; 1983 Feb; 23(2):245-7. PubMed ID: 6404218
[TBL] [Abstract][Full Text] [Related]
7. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.
Moellering RC; Wennersten C; Weinstein AJ
Antimicrob Agents Chemother; 1973 Apr; 3(4):526-9. PubMed ID: 4208292
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
[TBL] [Abstract][Full Text] [Related]
10. Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis.
Moellering RC; Korzeniowski OM; Sande MA; Wennersten CB
J Infect Dis; 1979 Aug; 140(2):203-8. PubMed ID: 113469
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
12. Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.
Ikeda DP; Barry AL; Andersen SG
Diagn Microbiol Infect Dis; 1984 Jun; 2(3):171-7. PubMed ID: 6430629
[TBL] [Abstract][Full Text] [Related]
13. Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.
Calderwood SA; Wennersten C; Moellering RC; Kunz LJ; Krogstad DJ
Antimicrob Agents Chemother; 1977 Sep; 12(3):401-5. PubMed ID: 242911
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
Livingston WK; Elliott AM; Cobbs CG
Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
[TBL] [Abstract][Full Text] [Related]
15. Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.
Carrizosa J; Levison ME
Antimicrob Agents Chemother; 1981 Sep; 20(3):405-9. PubMed ID: 6795989
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
Horadam VW; Smilack JD; Montgomery CL; Werringloer J
Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
[TBL] [Abstract][Full Text] [Related]
18. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
19. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
20. Resistance of enterococci to antibiotic combinations.
Chen HY
J Antimicrob Chemother; 1986 Jul; 18(1):1-4. PubMed ID: 3093442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
